This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (19)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Suzie C. Tindall, MD; Bruce H. Peters, MD; John R. Caverley, MD; Harry E. Sarles, MD; Jay C. Fish, MD

Arch Neurol. 1973;29(3):202-203.

Abstract
Thoracic duct lymphocyte depletion, a technique that selectively suppresses cellular immune defenses, was performed in a patient with myasthenia gravis. The patient demonstrated a 70% reduction in anticholinesterase medication requirement. These data lend further support to the apparent relationship between myasthenia gravis, the thymus, and cell-mediated immunity and implicate the lymphocyte, or a substance bound to it, as a contributing factor in myasthenia gravis.

Author Affiliations
Galveston, Tex

From the Division of Neurology (Drs. Tindall, Peters, and Caverley), and the departments of medicine (Dr. Sarles), and surgery (Dr. Fish), the University of Texas Medical Branch, Galveston.

Footnotes
Accepted for publication May 17, 1973.

Reprint requests to Division of Neurology, Emory University School of Medicine, 69 Butler St, Atlanta, GA 30303 (Dr. Tindall).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Serum Globulin in Myasthenia Gravis: Inhibition of agr-Bungarotoxin Binding to Acetylcholine Receptors
Almon et al.
Science 1974;186:55-57.
ABSTRACT